15.55
+0.32%
Close of 9 Nov 2026, in SEK
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Bactiguard Holding
Its shares trade on Nasdaq Stockholm under the ticker BACTI B.ST. It has been listed since 19 June 2014. In the fiscal year to 31 December 2025, it reported revenue of SEK 215.9m and a net loss of SEK 7.8m. At that date it held total assets of SEK 545.1m and shareholders' equity of SEK 314.9m.
Bactiguard Holding AB is a medical device company, which engages in the development and supply of infection protection solutions. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2014-06-19. Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. The company consists of the noble metals: gold, palladium and silver, which reduces the adhesion of bacteria to the coated surfaces. Its product portfolio includes: BIP Foley Catherer, made from medical grade latex, and BIP Foley Catheter - Silicone, used for drainage and irrigation of the bladder; BIP Endotracheal Tube, for general anesthesia, intensive care, and emergency medicine for airway management and mechanical ventilation; and BIP Central Venous Catherer, made of polyurethane and used to administer drugs and intravenous solutions, monitor pressure and blood sampling. The firm is also present in Portugal, via a distribution agreement with Socime Medical Ltd, and Zambia.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 19 Jun 2014
- Employees
- 180
- Website
- bactiguard.se ↗
Leadership
Pay as last reported
- Mr. Thomas Von KochChairman of the Board, since 2011SEK 500,000
- Ms. Christine LindChief Executive OfficerSEK 3.4m
- Mr. Patrick BachChief Financial Officer
- Ms. Kajsa Bjoerk-lundExecutive Vice President - Research and Development
- Mr. Sathish SubramaniamChief Technology Officer, since 2022
- Dr. Nathaniel BachrachChief Scientific Officer
- Ms. Nina NornholmHead of Communication and Investor Relations
- Mr. Jan StahlbergBoard MemberSEK 400,000
- Mr. Richard KuntzIndependent Board MemberSEK 400,000
- Ms. Anna MartlingIndependent Board MemberSEK 400,000
- Ms. Magdalena PerssonIndependent Board MemberSEK 400,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 33
- Environment
- 48
- Social
- 39
- Governance
- 12
- Direct emissions (scope 1)
- 2 t
- Energy emissions (scope 2)
- 914 t
- Value chain emissions (scope 3)
- 4,013 t
- Women in the workforce
- 61%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Bactiguard Holding AB possesses several strengths that contribute to its success in the market. These include:
Weaknesses
- Despite its strengths, Bactiguard Holding AB also faces certain weaknesses that could be potential areas for improvement:
Opportunities
- Bactiguard Holding AB can seize various opportunities to expand its market presence and improve its competitive position:
Threats
- Bactiguard Holding AB should also be vigilant to potential threats that could impact its growth and sustainability:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.